Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclization
- 1 February 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (3) , 491-496
- https://doi.org/10.1016/s0960-894x(99)00016-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Discovery of a Novel Non-Peptide Somatostatin Agonist with SST4 SelectivityJournal of the American Chemical Society, 1998
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Molecular and functional properties of somatostatin receptor subtypesMetabolism, 1996
- Identification of Ligand Binding Determinants in the Somatostatin Receptor Subtypes 1 and 2Journal of Biological Chemistry, 1996
- Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5)Endocrinology, 1994
- Design and synthesis of peptidomimetic inhibitors of HIV-1 protease and renin. Evidence for improved transportJournal of Medicinal Chemistry, 1994
- Effects of Somatostatin on Gastrointestinal Propagation and Absorption of Oral Glucose in ManDigestion, 1980
- Effects of Somatostatin on Hemostasis in BaboonsNew England Journal of Medicine, 1975
- Inhibition by Somatostatin of Glucagon and Insulin Release from the Perfused Rat Pancreas in Response to Arginine, Isoproterenol and Theophylline: Evidence for a Preferential Effect on Glucagon SecretionEndocrinology, 1975
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973